PE
RDY icon

PCM Encore’s Dr. Reddy's Laboratories RDY Stock Holding History

PCM Encore’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
93,212
+9,459
+11% +$128K 0.24% 79
2026
Q1 		$1.16M Buy
83,753
+2,555
+3% +$35.6K 0.24% 85
2025
Q4 		$1.14M Buy
+81,198
New +$1.14M 0.24% 85

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PCM Encore's RDY Position: Q2 2026 in Review

PCM Encore increased its Dr. Reddy's Laboratories (RDY) stake by 11% in Q2 2026, buying an estimated $128K and bringing the position to 93,212 shares worth $1.35M. The position accounts for 0.24% of the portfolio, ranked #79.

PCM Encore first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • PCM Encore held 93,212 shares of Dr. Reddy's Laboratories worth $1.35M as of Q2 2026.
  • PCM Encore bought 9,459 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $128K.
  • Dr. Reddy's Laboratories made up 0.24% of PCM Encore's portfolio in Q2 2026, its #79 holding.
  • PCM Encore first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.